Brief: Venus Remedies Secures Exclusive In-Licensing Rights From Infex Therapeutics
25/02/2025 04:47
Feb 25 (Reuters) - Venus Remedies Ltd VENR.NS :
* SECURES EXCLUSIVE IN-LICENSING RIGHTS FROM INFEX
THERAPEUTICS
* SECURES EXCLUSIVE IN-LICENSING RIGHTS TO DEVELOP,
COMMERCIALIZE
MET-X IN INDIA
Source text: ID:nBSE7MjRrY
Further company coverage: VENR.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage